Publications and Conference

Publications

• AS Akkewar, KMA Mishra, MG Kamble, S Kumar, J Dey, KK Sethi*. A mechanistic review on growing multiple therapeutic applications of lutein and its global market research. Phytotherapy Research, 2024, 38, 3190-3217. I.F.: 6.656

• R Podili, KMA Mishra, AS Akkewar, S Kumar, VVS Prasanna Kumari Rayala, Uttam Kulhari, Bidya D Sahu, Radhakrishnanand P, Kalyan K Sethi.* Design, synthesis, and histone deacetylase inhibition study of novel 4‐(2‐aminoethyl) phenol derivatives. Journal of Biochemical and Molecular Toxicology, e23591. I.F.: 3.568

• NM Vardhini, J Punia, S Jat, SD Pawar, N Devi, P Radhakrishnanand, Radhakrishnanand P, Murty USN, Saini A, Sethi KK, Kumar P. Purification and characterization of pure curcumin, desmethoxycurcumin, and bisdemethoxycurcumin from North-East India Lakadong turmeric (Curcuma longa). Journal of Chromatography A 1708, 464358. I.F.: 4.1

• KM Abha Mishra, R Podili, TS Pathlavath, KK Sethi*, A critical review on brain and heart axis response in COVID‐19 patients: Molecular mechanisms, mediators, biomarkers, and therapeutics. Journal of Biochemical and Molecular Toxicology 2023; 37 (8), e23409. I.F.: 3.568

• Hrushikesh S. Chaudhari, Omkar S. Palkar, KM Abha Mishra, Kalyan K. Sethi*. An extensive review on antifungal approaches in the treatment of mucormycosis Journal of . Journal of Biochemical and Molecular Toxicology 2023; 37, e23417, I.F.: 3.568

• Kalita SK, Pawar SD, Vernekar P, Pawar MA, Veena KS, Mishra A, Das P, Sethi KK, Radhakrishnanand P, Murty USN, Sahu PL, Dubey S, Sahu K, Upadhyay A, Kori RK, Kumar P. Synthesis and characterization of octopamine sulfate, norfenefrine sulfate and etilefrine sulfate reference materials for doping control. Journal of Chemical Technology and Biotechnology 2023; 98, 2318-2329, I.F.: 3.4

• Kumar GJ, Pawar SD, Pawar SR, et al. Process development for the total synthesis of the novel drug metabolite Carboxy toremifene as a standard reference material along with characterization and purity assessment for the Antidoping quality Control Purposes. Drug Test Anal. 2022; 1‐5. I.F.: 3.345

• MK Verma, S Roychowdhury, BD Sahu, A Mishra, KK Sethi*, CRISPR‐based point‐of‐care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes advanced for SARS‐CoV‐2 detection. Journal of Biochemical and Molecular Toxicology, e23113, 2022. I.F.: 3.568

• Trivedi MK, Panda P, Sethi KK, Gangwar M, Mondal SC, Jana S *. Solid and liquid state characterization of tetrahydrocurcumin using XRPD, FT-IR, DSC, TGA, LC-MS, GC-MS, NMR, and its biological activities. Journal of Pharmaceutical Analysis, 2020, 10, 334-345. I.F.: 14.026

• Sethi KK. Human Carbonic Anhydrase Inhibitors (hCAIs) a Druggable Target for Cancer Therapy. Editorial. EC Pharmacology and Toxicology, 4.4 (2017): 135-137.

• Trivedi MK, Dixit N, Panda P, Sethi KK, Jana S*. In-depth Investigation on Physicochemical and Thermal Properties of Magnesium (II) Gluconate Using Spectroscopic and Thermoanalytical Techniques. Journal of Pharmaceutical Analysis, 2017, 7, 332-337. I.F.: 14.026

• Trivedi MK, Panda P, Sethi KK, Jana S*. Liquid Chromatography Tandem Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy of Magnesium (II) Gluconate Solution. Journal of Solution Chemistry, 2017, 46, 896-907. I.F.: 2.0

• Trivedi MK, Sethi KK, Panda P, Jana S*. A comprehensive physicochemical, thermal, and spectroscopic characterization of zinc (II) chloride using X-ray diffraction, particle size distribution, differential scanning calorimetry, thermogravimetric analysis/differential thermogravimetric analysis, ultraviolet-visible, and Fourier transform-infrared spectroscopy. Int J Pharma Investig, 2017, 7, 33-44.

• Trivedi MK, Sethi KK, Panda P, Jana S*. Physicochemical, thermal, and spectroscopic characterization of sodium selenate using XRD, PSD, DSC, TGA/DTG, UV-vis, and FT- IR. Marmara Pharmaceutical Journal, 2017, 21(2), 311-318.

• Trivedi MK, Sethi KK, Panda P, Jana S*. Metabolite profiling of Withania somnifera roots hydroalcoholic extract using LC-MS, GC-MS and NMR spectroscopy. Chemistry and Biodiversity, 2017, 14, e1600280. I.F.: 2.745

• Sethi KK*, Nayak PK., Sarkar H, Verma SM. A rational approach towards the development of human carbonic anhydrase inhibitors as antiepileptic agent. Medicinal chemistry. 2016, 6, 405-410.

• Sethi KK*, Verma SM, Tanç M, Carta F, and Supuran CT. Carbonic Anhydrase Inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. Bioorganic & Medicinal Chemistry, 2014, 22, 1586-1595. I.F.: 3.641

• Sethi KK* and Verma SM. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors. Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, 29, 571-581. I.F.: 5.756

•  Sethi KK*, Vullo D, Verma SM, Tanç M, Carta F, and Supuran CT. Carbonic Anhydrase Inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII,  IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalic anhydride moiety. Bioorganic & Medicinal Chemistry, 2013, 21, 5973-5982. I.F.: 3.641

• Sethi KK*, Verma SM, Tanç M, Carta F, and Supuran CT. Carbonic Anhydrase Inhibitors: Synthesis and Inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII withbenzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalic anhydride moiety. Bioorganic & Medicinal Chemistry, 2013, 21(17), 5168-5174. I.F.: 3.641

• Brijesh Patel, Verma SM *, and Sethi KK. 3D-QSAR and Docking studies of N-hydroxy 1,8-naphthyridine 2-one analogues as Ribonuclease H Inhibitors. Letters in Drug Design & Discovery, 2013, 10(9), 823-835. I.F.: 1.169

• Sethi KK* and Verma SM. Pharmacophore modeling and 3D QSAR studies of novel human carbonic anhydrase IX inhibitors. Letters in Drug Design & Discovery, 2013, 10, 808-816. I.F.: 1.169

• Verma SM, Saha A, Mishra R, and Sethi KK*. 3D-QSAR study of some heterocyclic sulfonamide analogs as hCAII inhibitors. Letters in Drug Design & Discovery, 2012, 9, 581-586. I.F.: 1.169

• Mishra R *, Ganguly S, Sethi KK, Mazumder PM. Synthesis and Anticonvulsant Activity of Some Novel 2-Methyl Imidazole Derivatives. Letters in Drug Design & Discovery, 2012, 9(4), 402-408. I.F.: 1.169

• Sethi KK*, Pichikala JN, Sahoo SK, Suresh P. Carbonic Anhydrase I and II inhibition with natural products: Caffeine and Piperine. Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, 27, 97-100. I.F.: 5.756

• Sethi KK*, Verma SM, Kumar PM, Mishra R. Carbonic Anhydrase I and II inhibition with natural products: Leucas Cephalotes. Pharmacognosy Communication, 2011, 1, 40-45.

• Sethi KK*, Suresh P, and Mondal S. Carbonic Anhydrase I and II inhibition with natural products: Abrus Precatorius. Current Enzyme Inhibition, 2011, 7, 119-124.

• Sethi KK*, Verma SM, Prasanthi N, Annapurna MM. Synthesis, neurotoxicity, and anticonvulsant study of some benzothiazole analogs. Letters in Drug Design & Discovery, 2011, 8, 774-777. I.F.: 1.169.

• Hathi DK*, Bhatnagar SP, Sethi KK*. Development and Evaluation of Polyherbal Antidandruff Hail Oil. Pharmacognosy Journal. 2010, 2, 328-334. I.F.: 0.82

• Hathi DK*, Bhatnagar SP, Sethi KK*. Development and Evaluation of Polyherbal Antidandruff Hail Oil. Pharmacognosy Journal. 2010, 2, 328-334. I.F.: 0.82

• Sethi KK*, Verma SM, Prasanthi N, Sahoo SK, Parhi RN, Suresh P. 3D-QSAR study of Benzene Sulfonamides as human Carbonic Anhydrase II Inhibitor. Bioorganic and Medicinal Chemistry Letters, 2010, 20, 3089-3093. I.F.: 2.94

Conference Attended 

• Kalyan K Sethi, Pramod Dewangan, N. Padma, S. M. Verma. Docking studies of N, N1-bis substituted aryl guanidine derivatives as NMDA receptor antagonists. 13th Association of Pharmaceutical Teachers of India National Convention, Bilaspur, 2008, Chattishgarh, India.

• Kalyan Kumar Sethi, Kamble Mahesh Gopichand, KM Abha Mishra, Akkewar Ashish Sunil. Economical scale-up process development for the high yield and high purity lutein from the waste natural product. International Symposium on Recent Trends and Future Opportunities in Pharmaceuticals. November 10-12, 2022. National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar - 160062, Punjab (INDIA)

• Sethi KK, Mishra KA, Verma SM, Vullo D, Carta F, Supuran CT. Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties. International Symposium on Recent Trends and Future Opportunities in Pharmaceuticals. November 10-12, 2022. National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar - 160062, Punjab (INDIA)

• Sethi KK, Kumari Kaushiki (Best Poster Presentation Award) Economical scale-up process development for the high yield and high purity lutein from marigold. International Hybrid Conference BIOECONOMY 2023, 11-12 October 2023 at IIT Guwahati. 

• Juhi Dey, Kumari Kaushiki, Kalyan Kr. Sethi. “Design, Synthesis, and Pharmacological Evaluation of Novel Human Antigen R (HuR) Inhibitors” in the 4th Flow Chemistry and Natural Products Synthesis International Symposium on 18-19th December 2023 in NIPER, Kolkata, West Bengal, India.